‘Mirabegron’ is the most claimed substance after the enforcement of the Patent Linkage System
The substance, which has been claimed the most for patent trials after enforcement of the Pharmaceutical Patent Linkage System, was turned out to be the overactive bladder treatment, mirabegron.
CEO Hong-gi Lee of B2Pharm, a monitoring company for patent trials, stated that there were the total ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
